Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients: A Proof of Concept Study.

NCT04430660 is registered in ClinicalTrials.gov with Pennington Biomedical Research Center as lead sponsor.

NCT NCT04430660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04430660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients: A Proof of Concept Study.
Lead sponsor
Pennington Biomedical Research Center
Phase
Not applicable
Overall status
Completed
Start date
August 19, 2020
Completion date
May 4, 2022
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypoglycemia